The origin of human CD20+ T cells: a stolen identity?

The origin of human CD20+ T cells: a stolen identity?

Human T cells expressing CD20 play an important role in the defense against virus and cancer and are central in the pathogenesis of both malignancies and various autoimmune disorders. Therapeutic modulation of CD20+ T cells and the CD20 expression level is therefore of significant interest. In roden...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marina Rode von Essen, Lisbeth Egelykke Stolpe, Helle Bach Søndergaard, Finn Sellebjerg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Immunology
Subjects:	CD20+ T cells trogocytosis endogenous CD20 production MS4A1 CD20 on proliferating T cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1487530/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies
by: Malgorzata Bobrowicz, et al.
Published: (2024-12-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

Infiltration and subtype analysis of CD3 + CD20 + T cells in lung cancer
by: Liping Luo, et al.
Published: (2025-01-01)

CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
by: Dan Zhu, et al.
Published: (2024-12-01)

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
by: Twan Sia, BA, et al.
Published: (2025-05-01)

SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW
by: Francesca Pavanello, et al.
Published: (2016-11-01)

IMMUNOHISTOCHEMICALLY EVALUATION OF CD20 EXPRESSION IN PATIENTS WITH MULTIPLE MYELOMA
by: Irfan Yavasoglu, et al.
Published: (2014-08-01)

The screening and anti-Raji lymphoma effect of Chiloscyllium plagiosum anti-CD20 VNARs
by: Qingyu Ren, et al.
Published: (2024-12-01)

Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves Trogocytosis
by: Nazanin Ghasemi, et al.
Published: (2024-12-01)

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression
by: Oanh T. P. Nguyen, et al.
Published: (2024-12-01)

The Immune Contexture in Canine Anal Sac Adenocarcinoma: Immunohistochemical Quantification of Tumor-Infiltrating Lymphocytes and Tumor-Associated Macrophages with Image Analysis
by: Barbara Bacci, et al.
Published: (2024-12-01)

Development of Hemispherical 3D Models of Human Brain and B Cell Lymphomas Using On-Chip Cell Dome System
by: Ryotaro Kazama, et al.
Published: (2024-12-01)

锌指蛋白A20基因抑制缺氧诱导内皮细胞CD54的表达
by: 张剑凯, et al.
Published: (2008-01-01)

Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine
by: Sylvain Lamure, et al.
Published: (2025-01-01)

PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
by: Michele Bibas
Published: (2024-01-01)

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
by: Hovav Azuly, et al.
Published: (2024-12-01)

De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: the initial Iranian experience
by: Sepideh Paybast, et al.
Published: (2025-10-01)

Ocrelizumab-induced colitis—critical review and case series from a Romanian cohort of MS patients
by: Ileana Maria Vodă, et al.
Published: (2025-02-01)

Clinical Features of Patients with COVID-19 Recurrence During Hospitalization in the Omicron Variant Surge
by: Seki M, et al.
Published: (2024-11-01)

Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
by: André Aires Fernandes, et al.
Published: (2025-01-01)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
by: Dong Ki Lee, et al.
Published: (2024-12-01)

IgM Flare in Anti-MAG Neuropathy Post Rituximab Treatment: A Clinical Case and a Systematic Review of the Literature
by: Giovanni Siconolfi, et al.
Published: (2024-12-01)

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review
by: Chao Wang, et al.
Published: (2025-01-01)

Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01)

Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial
by: Miriam M. Moser, et al.
Published: (2024-12-01)

New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function
by: Filip Lewandowski, et al.
Published: (2024-11-01)

Interventional Effect and Mechanism of Acupuncture at Baihui （GV 20） and Qubin （GB 7） Acupoints on Rats with Acute Cerebral Hemorrhage
by: CHEN Qiuxin, et al.
Published: (2024-04-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

The utilization of cytology for intraoperative diagnosis of primary central nervous system lymphoma
by: Liwen Hu, et al.
Published: (2024-11-01)

Fusion Systems and Rank $2$ Simple Groups of Lie Type
by: Martin van Beek
Published: (2024-01-01)

A local-global principle for unipotent characters
by: Damiano Rossi
Published: (2024-01-01)

Persistent SARS-CoV-2 infection resolved after B-cell recovery in a patient with follicular lymphoma treated with B-cell depletion therapy
by: Yuriko Sueda, et al.
Published: (2024-01-01)

Comparative Analysis of AES, Blowfish, Twofish, Salsa20, and ChaCha20 for Image Encryption
by: Rebwar Khalid Muhammed, et al.
Published: (2024-05-01)

Mortality and immunological indicators of men who have sex with men living with HIV on antiretroviral therapy: a 10-year retrospective cohort study in Southern China
by: Huaxiang Lu, et al.
Published: (2025-01-01)

THE TIME OF THE G20, BRAZIL IN THE WORLD AND THE WORLD IN BRAZIL: AN INTRODUCTION
by: André de Mello e Souza, et al.
Published: (2024-04-01)

CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
by: John F. Imbery, et al.
Published: (2024-09-01)

Obinutuzumab-induced acute thrombocytopenia: a case report and literature review
by: Xuelin Dou, et al.
Published: (2024-12-01)

Case report: paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab
by: Jingjing Dou, et al.
Published: (2024-12-01)

Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
by: Wannakorn Khopanlert, et al.
Published: (2024-09-01)